A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• VP Head Cardiorenal Clinical Development - Bayer AG
• SVP Integrated Product Team Lead CHF - AskBio